We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$180M
AUM Growth
-$16.6M
Cap. Flow
-$8.49M
Cap. Flow %
-4.71%
Top 10 Hldgs %
42.71%
Holding
128
New
34
Increased
5
Reduced
15
Closed
37

Top Buys

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$4.11M
2
PEN icon
Penumbra
PEN
+$4.08M
3
ATEC icon
Alphatec Holdings
ATEC
+$3.82M
4
INSP icon
Inspire Medical Systems
INSP
+$3.16M
5
VREX icon
Varex Imaging
VREX
+$3.14M

Top Sells

Rank Stock Value
1
AKRO
Akero Therapeutics
AKRO
+$6.85M
2
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
+$6.47M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$5.29M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$4.95M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$4.32M

Sector Composition

Rank Sector Weight
1 Healthcare 85.22%
2 Financials 3.64%
3 Technology 0.85%
4 Communication Services 0.51%
5 Materials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCDIW
76
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$14.5K 0.01%
600,000
– –
VSEEW
77
DELISTED
VSEE HEALTH INC WTS 29
VSEEW
$12.8K 0.01%
150,000
– –
SLNAW
78
DELISTED
Selina Hospitality PLC Warrant
SLNAW
$10.1K 0.01%
101,439
– –
NXLIW
79
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$9.97K 0.01%
105,000
– –
CDTTW
80
CDT Equity Inc Warrant
CDTTW
$1.87M
$9K 0.01%
+100,000
New +$7.56K
TGVCW
81
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$9K 0.01%
+200,000
New +$14K
CYCUW
82
Cycurion Inc Warrant
CYCUW
$311K
$8.9K ﹤0.01%
+100,000
New +$7.8K
SRZNW icon
83
Surrozen Inc Warrant
SRZNW
$8.86K
$8.22K ﹤0.01%
82,233
– –
OHAAW
84
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$7.67K ﹤0.01%
50,000
– –
EUCRW
85
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$4.82K ﹤0.01%
133,333
– –
MOBXW icon
86
Mobix Labs Warrants
MOBXW
$4.71K ﹤0.01%
150,000
– –
MITAW
87
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$4.11K ﹤0.01%
28,333
– –
PSQH.WS icon
88
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
$3.6K ﹤0.01%
16,666
– –
BTMWW
89
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$2K ﹤0.01%
+50,000
New +$4.92K
TCBPW
90
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$1.88K ﹤0.01%
18,823
– –
ABEO icon
91
Abeona Therapeutics
ABEO
$413M
– –
-108,696
Closed -$335K
AKRO
92
DELISTED
Akero Therapeutics
AKRO
– –
-125,000
Closed -$6.85M
ATXS
93
CALL
DELISTED
Astria Therapeutics
ATXS
– –
-7,700
Closed -$115K
COLL icon
94
Collegium Pharmaceutical
COLL
$956M
– –
-90,000
Closed -$2.09M
ESPR
95
DELISTED
Esperion Therapeutics
ESPR
– –
-620,000
Closed -$3.86M
KURA icon
96
Kura Oncology
KURA
$850M
– –
-28,198
Closed -$350K
MDWD icon
97
MediWound
MDWD
$185M
– –
-27,286
Closed -$368K
NBIX icon
98
Neurocrine Biosciences
NBIX
$16.6B
– –
-17,500
Closed -$2.09M
OBIO icon
99
Orchestra BioMed
OBIO
$254M
– –
-10,000
Closed -$99.8K
OTLK icon
100
Outlook Therapeutics
OTLK
$191M
– –
-166,370
Closed -$3.59M
2 3
4
5 6

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Altium Capital Management held 128 positions worth $180M, down 8.5% from $197M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Altium Capital Management withdrew a net $8.49M in Q1 2023, closing 37 positions and reducing 15 holdings. Its most notable exit was Akero Therapeutics, an estimated $6.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 89% a quarter earlier, followed by Financials and Technology.

Against the trend, Altium Capital Management opened a new position in Avadel Pharmaceuticals worth $4.58M.

  • Altium Capital Management's largest Q1 2023 buy was Avadel Pharmaceuticals: 500,000 shares worth $4.58M.
  • Altium Capital Management added most to CTI BioPharma Corp. (DE) Common Stock in Q1 2023, an estimated $2.08M increase.
  • Altium Capital Management's biggest Q1 2023 reduction was PepperLime Health Acquisition Corporation Class A Ordinary Share, cutting an estimated $6.47M.
  • Altium Capital Management fully exited Akero Therapeutics in Q1 2023, selling an estimated $6.85M.
  • Altium Capital Management's ten largest holdings make up 43% of its $180M portfolio in Q1 2023.
  • Altium Capital Management opened 34 new positions and closed 37 in Q1 2023.
  • Altium Capital Management's portfolio value fell 8.5% quarter-over-quarter to $180M.

Based on Altium Capital Management's 13F filing for Q1 2023, filed 15 May 2023.